229 related articles for article (PubMed ID: 2423636)
1. An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralization.
Minson AC; Hodgman TC; Digard P; Hancock DC; Bell SE; Buckmaster EA
J Gen Virol; 1986 Jun; 67 ( Pt 6)():1001-13. PubMed ID: 2423636
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.
Highlander SL; Sutherland SL; Gage PJ; Johnson DC; Levine M; Glorioso JC
J Virol; 1987 Nov; 61(11):3356-64. PubMed ID: 2444713
[TBL] [Abstract][Full Text] [Related]
3. Characterization and sequence analyses of antibody-selected antigenic variants of herpes simplex virus show a conformationally complex epitope on glycoprotein H.
Gompels UA; Carss AL; Saxby C; Hancock DC; Forrester A; Minson AC
J Virol; 1991 May; 65(5):2393-401. PubMed ID: 1707982
[TBL] [Abstract][Full Text] [Related]
4. Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.
Holland TC; Marlin SD; Levine M; Glorioso J
J Virol; 1983 Feb; 45(2):672-82. PubMed ID: 6187935
[TBL] [Abstract][Full Text] [Related]
5. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
6. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
Roberts PL; Duncan BE; Raybould TJ; Watson DH
J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
[TBL] [Abstract][Full Text] [Related]
7. Localization of epitopes of herpes simplex virus type 1 glycoprotein D.
Eisenberg RJ; Long D; Ponce de Leon M; Matthews JT; Spear PG; Gibson MG; Lasky LA; Berman P; Golub E; Cohen GH
J Virol; 1985 Feb; 53(2):634-44. PubMed ID: 2578577
[TBL] [Abstract][Full Text] [Related]
8. Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.
Kümel G; Kaerner HC; Levine M; Schröder CH; Glorioso JC
J Virol; 1985 Dec; 56(3):930-7. PubMed ID: 2415719
[TBL] [Abstract][Full Text] [Related]
9. Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody.
Cohen GH; Dietzschold B; Ponce de Leon M; Long D; Golub E; Varrichio A; Pereira L; Eisenberg RJ
J Virol; 1984 Jan; 49(1):102-8. PubMed ID: 6197535
[TBL] [Abstract][Full Text] [Related]
10. Domains of herpes simplex virus I glycoprotein B that function in virus penetration, cell-to-cell spread, and cell fusion.
Navarro D; Paz P; Pereira L
Virology; 1992 Jan; 186(1):99-112. PubMed ID: 1370130
[TBL] [Abstract][Full Text] [Related]
11. Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance.
Glaser AL; de Vries AA; Dubovi EJ
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2223-33. PubMed ID: 7561759
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
Orvell C; Norrby E; Mufson MA
J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration.
Highlander SL; Cai WH; Person S; Levine M; Glorioso JC
J Virol; 1988 Jun; 62(6):1881-8. PubMed ID: 2452895
[TBL] [Abstract][Full Text] [Related]
14. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans.
Cairns TM; Huang ZY; Whitbeck JC; Ponce de Leon M; Lou H; Wald A; Krummenacher C; Eisenberg RJ; Cohen GH
J Virol; 2014 Nov; 88(21):12612-22. PubMed ID: 25142599
[TBL] [Abstract][Full Text] [Related]
15. Virus, strain, and epitope specificities of neutralizing bovine monoclonal antibodies to bovine herpesvirus 1 glycoproteins gB, gC, and gD, with sequence and molecular model analysis.
Levings RL; Collins JK; Patterson PA; Roth JA
Vet Immunol Immunopathol; 2015 Apr; 164(3-4):179-93. PubMed ID: 25771882
[TBL] [Abstract][Full Text] [Related]
16. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
[TBL] [Abstract][Full Text] [Related]
17. Domain structure of herpes simplex virus 1 glycoprotein B: neutralizing epitopes map in regions of continuous and discontinuous residues.
Pereira L; Ali M; Kousoulas K; Huo B; Banks T
Virology; 1989 Sep; 172(1):11-24. PubMed ID: 2475970
[TBL] [Abstract][Full Text] [Related]
18. Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies.
Liu DX; Gompels UA; Foa-Tomasi L; Campadelli-Fiume G
Virology; 1993 Nov; 197(1):12-22. PubMed ID: 7692666
[TBL] [Abstract][Full Text] [Related]
19. Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies.
Fuller AO; Spear PG
J Virol; 1985 Aug; 55(2):475-82. PubMed ID: 2991570
[TBL] [Abstract][Full Text] [Related]
20. Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions.
Para MF; Parish ML; Noble AG; Spear PG
J Virol; 1985 Aug; 55(2):483-8. PubMed ID: 2991571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
